Orca Bio Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$192M
Lead Investor(s):Lightspeed Venture Partners, Data Collective, 8VC

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Orca Bio's estimated annual revenue is currently $11.7M per year.(?)
  • Orca Bio's estimated revenue per employee is $201,000
  • Orca Bio's total funding is $192M.

Employee Data

  • Orca Bio has 58 Employees.(?)
  • Orca Bio grew their employee count by 32% last year.
  • Orca Bio currently has 1 job openings.

Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patientsᅢᄁ¬ツᆲ¬トᄁ diseased blood and immune system with a healthy one. Our manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling us to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Our talented team is driven by a passion for science and compassion for patients.